Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer is a phase 3, randomised interventional study registered as NCT03975049 by Sixth Affiliated Hospital, Sun Yat-sen University, with a registry enrolment figure of 933 participants, started 2019-08 and due to reach its primary completion in 2024-07. Interventions recorded: Chemoradiation; FOLFOXIRI Protocol; Folfox Protocol. Conditions listed: Rectal Cancer; Chemotherapy Effect. Primary outcome: Disease-free survival. Colorectal eligibility wording from the registry: "* 2）Histological diagnosis of rectal adenocarcinoma;". No results are recorded here; the registry entry is the source.